<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>Data collection tools, sources, and outcome measures</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Data to be collected</th>
    <th>Data source</th>
    <th>Outcomes measure</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="13">TB-HIV integration indicators</td>
    <td/>
    <td> Clinical outcomes</td>
   </tr>
   <tr>
    <td>TIER.Net, community care givers, autopsy reports</td>
    <td>- Mortality rates—number of deaths among TB and HIV patients accessing care in study clinics from date clinic enrolled to 18 months post enrolment.</td>
   </tr>
   <tr>
    <td>TIER.Net</td>
    <td>- Proportion of patients retained in care—proportion of HIV-infected patients enrolled in care at clinics and alive 12 months.</td>
   </tr>
   <tr>
    <td>TIER.Net</td>
    <td>- Viral load testing coverage—proportion of patients on ART with viral loads test done among those eligible for viral load test at requested time points.</td>
   </tr>
   <tr>
    <td>TIER.Net</td>
    <td>- Viral load suppression—proportion of patients with undetectable viral load tests among those receiving 12 monthly viral load test.</td>
   </tr>
   <tr>
    <td>TIER.Net and clinic TB registers</td>
    <td>- TB treatment outcomes at end of study period—
     <break/>- Cure rates: proportion of new smear-positive patients that are smear-negative in the last month of treatment and on at least one other occasion at least 30 days prior.
     <break/>- Loss to follow-up rates: proportion of new smear-positive patients that interrupted TB treatment for 2 consecutive months or more.
     <break/>- Treatment failure rates: Proportion of new smear-positive patients that are smear-positive at the end of TB treatment period.
     <break/>- Death rate: proportion of new smear-positive patients that died during TB treatment.
     <break/>- Transfer-out rate: proportion of new smear-positive pulmonary TB patients registered that were transferred to another district and for whom the TB treatment outcome is unknown.
    </td>
   </tr>
   <tr>
    <td/>
    <td rowspan="2">  
     <italic>Process outcome</italic>
     <break/>- HCT Coverage—proportion of patients with unknown HIV status tested for HIV
    </td>
   </tr>
   <tr>
    <td>TIER.Net, DHIS and clinic-based registers</td>
   </tr>
   <tr>
    <td>TIER.Net, DHIS and clinic-based registers</td>
    <td>- Co-infection—proportion of TB patients co-infected with HIV</td>
   </tr>
   <tr>
    <td>TIER.Net, DHIS and clinic-based registers</td>
    <td>- Time to ART initiation (in days)—time in days between diagnosis of HIV infection diagnosis and ART initiation.</td>
   </tr>
   <tr>
    <td>TIER.Net, DHIS and clinic-based registers</td>
    <td>- TB screening coverage among HIV-infected patients—
     <break/>a) Proportion of HIV-infected patients receiving TB screening and
     <break/>b) Frequency of TB screening during follow-up
    </td>
   </tr>
   <tr>
    <td>TIER.Net, DHIS and clinic-based registers</td>
    <td>- IPT initiation—
     <break/>a) Proportion of HIV-infected TB negative patients initiated on IPT and
     <break/>b) Proportion of patients completing IPT course.
    </td>
   </tr>
   <tr>
    <td>TIER.Net, DHIS and clinic-based registers</td>
    <td>- CPT uptake among co-infected patients—proportion of eligible HIV-positive patients initiated on CPT</td>
   </tr>
   <tr>
    <td>TB-HIV service integration in the facility macro-environment</td>
    <td>Survey instrument developed by Uyei et al. 2014 [
     <xref ref-type="bibr" rid="CR7">7</xref>]
    </td>
    <td>Measured TB-HIV integration in terms of:
     <break/>➢ Organization—such as co-location of services, combined patient records, information management, and joint training
     <break/>➢ Structure—existent practice of joint service delivery,
     <break/>➢ Process—behavior and practice of delivering services
     <break/>➢ Culture—work place culture and personal identification with integrated service delivery
    </td>
   </tr>
   <tr>
    <td>Clinic profile tool aimed at assessing clinics’ infrastructure, capacity, and systems in place to implement TB-HIV integration services</td>
    <td>A CAPRISA designed tool</td>
    <td>- Resources inventory and needs for implementation of TB-HIV integration services, e.g., available guidelines, protocols, policies, trained staff.
     <break/>- Existing quality improvement interventions, processes and measurements
     <break/>- District level leadership and support
    </td>
   </tr>
   <tr>
    <td>Clinic culture, leadership, resources, etc.</td>
    <td>The COACH tool designed by Bergstrom et al. 2015 [
     <xref ref-type="bibr" rid="CR56">56</xref>]
    </td>
    <td>- Clinic leadership and support
     <break/>- Staff knowledge and skills
     <break/>- Perceptions of work culture at PHC
    </td>
   </tr>
   <tr>
    <td>Staff Work-related Quality of Life</td>
    <td>WHO Work-related Quality of Life Scale</td>
    <td>Work-related quality of life for staff at PHC</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
